Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pasquier

Showing results (41-50 of 159) with videos related to

Pageof 16
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 2, 2020
The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic reviewMarion Tonneau, Arielle Elkrief, David Pasquier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 21, 2025
Stereotactic radiotherapy for lung cancer: Influence of prescription modality on clinical outcomeDelphine Antoni, Ulrike Schick, Delphine Jarnet, et al.
International Journal of Molecular Sciences|September 18, 2020
Combination of High Dose Hypofractionated Radiotherapy with Anti-PD1 Single Dose Immunotherapy Leads to a Th1 Immune Activation Resulting in a Complete Clinical Response in a Melanoma PatientClara Milhem, Olivier Moralès, Céline Ingelaere, et al.
Frontiers in Oncology|March 5, 2019
Stereotactic Re-irradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: Preliminary ResultsJonathan Olivier, Laurent Basson, Philippe Puech, et al.
Frontiers in Oncology|November 15, 2021
Stereotactic Body Radiation Therapy for Oligometastatic Breast Cancer: A Retrospective Multicenter StudyPauline Lemoine, Marie Bruand, Emmanuel Kammerer, et al.
Frontiers in Oncology|August 27, 2019
Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland MetastasesCyrielle Scouarnec, David Pasquier, Joel Luu, et al.
Scientific Reports|July 12, 2018
Diffusion weighted MRI as an early predictor of tumor response to hypofractionated stereotactic boost for prostate cancerDavid Pasquier, Abderraouf Hadj Henni, Alexandre Escande, et al.
Physics in Medicine and Biology|February 14, 2020
MR to CT synthesis with multicenter data in the pelvic area using a conditional generative adversarial networkKévin N D Brou Boni, John Klein, Ludovic Vanquin, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2019
A Multicenter Phase 2 study of Hypofractionated Stereostatic Boost in Intermediate Risk Prostate Carcinoma: A 5-Year Analysis of the CKNO-PRO TrialDavid Pasquier, Didier Peiffert, Philippe Nickers, et al.
Frontiers in Oncology|August 19, 2016
Comparison of Automated Atlas-Based Segmentation Software for Postoperative Prostate Cancer RadiotherapyGrégory Delpon, Alexandre Escande, Timothée Ruef, et al.
Pageof 16

Showing results (41-50 of 159) with videos related to

Sort By:
Pageof 16
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 2, 2020
The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic reviewMarion Tonneau, Arielle Elkrief, David Pasquier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 21, 2025
Stereotactic radiotherapy for lung cancer: Influence of prescription modality on clinical outcomeDelphine Antoni, Ulrike Schick, Delphine Jarnet, et al.
International Journal of Molecular Sciences|September 18, 2020
Combination of High Dose Hypofractionated Radiotherapy with Anti-PD1 Single Dose Immunotherapy Leads to a Th1 Immune Activation Resulting in a Complete Clinical Response in a Melanoma PatientClara Milhem, Olivier Moralès, Céline Ingelaere, et al.
Frontiers in Oncology|March 5, 2019
Stereotactic Re-irradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: Preliminary ResultsJonathan Olivier, Laurent Basson, Philippe Puech, et al.
Frontiers in Oncology|November 15, 2021
Stereotactic Body Radiation Therapy for Oligometastatic Breast Cancer: A Retrospective Multicenter StudyPauline Lemoine, Marie Bruand, Emmanuel Kammerer, et al.
Frontiers in Oncology|August 27, 2019
Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland MetastasesCyrielle Scouarnec, David Pasquier, Joel Luu, et al.
Scientific Reports|July 12, 2018
Diffusion weighted MRI as an early predictor of tumor response to hypofractionated stereotactic boost for prostate cancerDavid Pasquier, Abderraouf Hadj Henni, Alexandre Escande, et al.
Physics in Medicine and Biology|February 14, 2020
MR to CT synthesis with multicenter data in the pelvic area using a conditional generative adversarial networkKévin N D Brou Boni, John Klein, Ludovic Vanquin, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2019
A Multicenter Phase 2 study of Hypofractionated Stereostatic Boost in Intermediate Risk Prostate Carcinoma: A 5-Year Analysis of the CKNO-PRO TrialDavid Pasquier, Didier Peiffert, Philippe Nickers, et al.
Frontiers in Oncology|August 19, 2016
Comparison of Automated Atlas-Based Segmentation Software for Postoperative Prostate Cancer RadiotherapyGrégory Delpon, Alexandre Escande, Timothée Ruef, et al.
Pageof 16